Start
Browse by Day
Browse by Session Type
Speaker/Author Index
Personal Scheduler
Browse Handouts
WAC 2011 Home
10-3PS
Prostaglandin D2 (PGD2): Therapeutic Implications
Wednesday, 7 December 2011: 09:25 - 09:50
Costa Maya (Cancún Center)
•
PGD2 for WAO.ppt
Andrew Wardlaw
,
Infection Immunity and Inflammation, Institute for Lung Health, Leicester, United Kingdom